Xtrackers MSCI World Quality UCITS ETF 1C EUR is a equity ETF from Xtrackers tracking the MSCI World Quality index through physical replication. Domiciled in Ireland and launched in 2014, the fund manages about 2.8 bn € and charges a TER of 0.25% — 25 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Xtrackers MSCI World Quality UCITS ETF 1C EUR competes with 261 other products in the same class and region (Equity, Developed markets): it ranks 38th by fund size and 93rd by ongoing cost, with a TER of 0.25% against a group median of 0.26%. It has been listed since 2014, 12 years of track record.
On a €10,000 investment the TER costs 25 € a year, against 26 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 34.7% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Apple Inc. | 5.1% |
| NVIDIA Corporation | 4.8% |
| Microsoft Corporation | 4.7% |
| ASML Holding N.V. | 3.5% |
| Visa Inc. Class A | 3.3% |
| Meta Platforms Inc. | 3.3% |
| Lam Research Corp | 2.8% |
| Eli Lilly and Company | 2.6% |
| Applied Materials Inc | 2.4% |
| The TJX Companies Inc | 2.2% |
| Borsa Italiana | XDEQ | EUR |
| XETRA | XDEQ | EUR |
| Francoforte | XDEQ | EUR |
| London Stock Exchange | XDEQ | GBX |
| SIX Swiss Exchange | XDEQ | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.